Biomarin Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 19.82 M | $1.12 B | 3.57% | 10.33% |
| DODGE & COX | 05/14/2026 | 14.56 M | $822.59 M | -0.07% | 7.59% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/11/2026 | 14.19 M | $801.82 M | -2.44% | 7.40% |
| 05/15/2026 | 8.64 M | $488.25 M | 100.00% | 4.51% | |
| 05/08/2026 | 8.30 M | $468.78 M | 100.00% | 4.33% | |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 7.68 M | $429.35 M | 14.80% | 4.00% |
| STATE STREET CORP | 05/15/2026 | 7.30 M | $412.10 M | -3.03% | 3.80% |
| VIKING GLOBAL INVESTORS LP | 05/15/2026 | 7.06 M | $398.94 M | 16.98% | 3.68% |
| CITADEL ADVISORS LLC | 05/15/2026 | 4.51 M | $254.92 M | 230.67% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 3.82 M | $215.81 M | 3.96% | 1.99% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 3.80 M | $214.80 M | 14.49% | 1.98% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 3.58 M | $201.95 M | 19.17% | 1.86% |
| FMR LLC | 05/15/2026 | 3.57 M | $201.50 M | 94.17% | 1.86% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 05/13/2026 | 3.49 M | $197.23 M | 37.06% | 1.82% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 3.01 M | $170.05 M | -0.90% | 1.57% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/20/2026 | 1.92 M | $108.50 M | 35.35% | 1.00% |
| FIRST TRUST ADVISORS LP | 05/13/2026 | 1.67 M | $94.48 M | 43.34% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.59 M | $89.69 M | 11.52% | 0.83% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.59 M | $89.61 M | 2.48% | 0.83% |
| UBS GROUP AG | 05/05/2026 | 1.50 M | $84.56 M | -32.32% | 0.78% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 1.36 M | $76.98 M | 100.00% | 0.71% |
| MORGAN STANLEY | 05/15/2026 | 1.32 M | $74.66 M | -42.92% | 0.69% |
| 05/14/2026 | 1.27 M | $71.65 M | 100.00% | 0.66% | |
| DNB ASSET MANAGEMENT AS | 05/14/2026 | 1.22 M | $69.00 M | -10.16% | 0.64% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 1.20 M | $67.74 M | 173.28% | 0.63% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.19 M | $67.46 M | 100.00% | 0.62% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 1.19 M | $67.10 M | -7.01% | 0.62% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 1.17 M | $66.29 M | -19.91% | 0.61% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 1.15 M | $64.96 M | -50.00% | 0.60% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 1.14 M | $64.67 M | -6.94% | 0.60% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 1.02 M | $57.89 M | -22.65% | 0.53% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 974.78 K | $55.07 M | 45.49% | 0.51% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 05/14/2026 | 945.60 K | $53.42 M | -9.84% | 0.49% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 936.95 K | $52.93 M | 8.38% | 0.49% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 933.88 K | $52.75 M | 881.99% | 0.49% |
| RIVER ROAD ASSET MANAGEMENT, LLC | 04/30/2026 | 917.61 K | $51.84 M | 1.24% | 0.48% |
| LSV ASSET MANAGEMENT | 05/11/2026 | 884.80 K | $49.98 M | 0.29% | 0.46% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 857.01 K | $48.41 M | 210.14% | 0.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 851.56 K | $48.10 M | 100.00% | 0.44% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 850.82 K | $48.06 M | 33.21% | 0.44% |
| SWEDBANK AB | 04/29/2026 | 792.19 K | $44.75 M | -0.57% | 0.41% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 781.98 K | $44.17 M | 12.17% | 0.41% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 739.40 K | $41.77 M | 1.08% | 0.39% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 716.52 K | $40.48 M | -8.73% | 0.37% |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 04/22/2026 | 714.54 K | $40.36 M | 0.08% | 0.37% |
| LOOMIS SAYLES & CO L P | 05/14/2026 | 713.80 K | $40.32 M | 0.28% | 0.37% |
| NUVEEN, LLC | 04/30/2026 | 705.20 K | $39.84 M | 3.76% | 0.37% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 689.72 K | $38.96 M | -51.99% | 0.36% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 05/13/2026 | 686.03 K | $38.75 M | 3.24% | 0.36% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 685.18 K | $38.71 M | -8.18% | 0.36% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biomarin Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 863 institutional investors and hedge funds held shares of Biomarin Pharmaceutical Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 19.82 M
DODGE & COX: 14.56 M
PRIMECAP MANAGEMENT CO/CA/: 14.19 M
AQR CAPITAL MANAGEMENT LLC: 7.68 M
STATE STREET CORP: 7.3 M
VIKING GLOBAL INVESTORS LP: 7.06 M
95.75% of Biomarin Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 243.29 M shares in the last 24 months. This purchase volume represents approximately $14.81 B in transactions.